|
|
| med.appl. |
degradation-related impurities (Degradation Product: An impurity resulting from a chemical change in the drug substance brought about during manufacture and/or storage of the new drug product by the effect of, for example, light, temperature, pH, water, or by reaction with an excipient and/or the immediate container closure system Jenny1801) |
| pharm. |
specific impurities (CRINKUM-CRANKUM) |
| pharma. |
related substances (ГФ. + R elated Substances – R elated substances are structurally related to a drug substance. These substances may be (a) id entified or unident ified impurities arisin g from the synthesis manufacturing process, such as star ting materials, intermediates, or by – products, and do not increase on stora ge, or (b) identified or un identified degra dation products that result from drug substance or drug produc t manufacturing processes or arise during storage of a material amatsyuk) |
|
|
| pharma. |
drug-related impurity (igisheva); related compound (igisheva); related substance (igisheva) |
